NK Cells
Natural Killer cells (NK cells) are a type of immune cell that plays a critical role in the body's defense against cancer and other infections. These cells derived from lymphoid stem cells are important components of the innate (non-specific) immune system. They recognize and kill cells that have been infected with viruses or that have become cancerous. NK cells identify and bind to target cells through a range of receptors on their surface, including activating receptors and inhibitory receptors. The activating receptors recognize molecules that are expressed on the surface of diseased cells or stressed normal cells, while inhibitory receptors recognize MHC class I molecules expressed on healthy cells. This balance between activating and inhibitory receptors has made NK cells an integral part of immunotherapy research. Recent studies have shown that NK cells have a unique ability to directly target cancer cells without the need for antigen-specific activation. It is believed that enhancing NK cell function could be a potential avenue for the development of new cancer treatments, particularly when combined with other therapeutic agents such as checkpoint inhibitors. In the field of hematology and oncology, NK cells are being studied for their ability to treat a range of malignancies including leukemia, lymphoma, and solid tumors. Research is focused on developing methods to increase the number and activity of NK cells in the body, as well as identifying new methods to selectively target cancerous cells while sparing normal cells. Overall, NK cells are essential components of the immune system, and research in this field has great potential to improve cancer treatments across the board.
← Hematology Research and Oncology Research